Prostate Cancer

Featured

Videos
Definitive vs Conservative Treatments for Older Men With Prostate Cancer
Sagar Patel, MD, discusses utilization trends and survival outcomes among guideline-supported treatment options in older men with high-risk prostate cancer.
Videos
Enzalutamide vs Apalutamide, Darolutamide, and Bicalutamide for Nonmetastatic CRPC
Tomasz Beer, MD, discusses results from a network meta-analysis comparing the efficacy of enzalutamide vs apalutamide,…
Research Report
Clinical Pathways Utilization and Total Cost of Care for the Treatment of Prostate Cancer
Karen A Sereday, MS, and colleagues present an analysis on adherence to multidisciplinary clinical pathways to…
Videos
Provider Preferences for Prostate Cancer: Medical Oncologists vs Urologists
Ajeet Gajra, FACP, MD, discusses differences in referral patterns and treatment preferences between medical oncologists…
Videos
Researchers Identify Molecular Determinants of Apalutamide Response in Nonmetastatic CRPC
Felix Feng, MD, discusses results from exploratory analysis of the phase 3 SPARTAN trial, which investigated potential…

News

Health Care Spending for High-Resource Patients With Prostate Cancer
RT Added to ADT Cost-Effective vs ADT Alone for Metastatic Prostate Cancer
Comparative Effectiveness of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer
Long-Term QOL in Prostate Cancer Treated With Ultra-Hypofractionation RT vs Conventionally Fractioned RT

Guideline Updates

AUA, ASTRO, and SUO Release Consensus Guideline on Advanced Prostate Cancer

Interviews

Novel Liquid Biopsy for Prostate Cancer Projected to Save Millions for US Health Care System

Videos

Definitive vs Conservative Treatments for Older Men With Prostate Cancer

Podcast

Episode 52: Advances in Prostate Cancer With Neeraj Agarwal

Conference Coverage

Determinants Impacting Provider Decisions to Prescribe Low-Value Prostate Cancer Treatment